Search Results - "Beyer, David"

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial by Hamstra, Daniel A., MD, PhD, Mariados, Neil, MD, Sylvester, John, MD, Shah, Dhiren, MD, Karsh, Lawrence, MD, Hudes, Richard, MD, Beyer, David, MD, Kurtzman, Steven, MD, Bogart, Jeffrey, MD, Hsi, R. Alex, MD, Kos, Michael, MD, Ellis, Rodney, MD, Logsdon, Mark, MD, Zimberg, Shawn, MD, Forsythe, Kevin, MD, Zhang, Hong, MD, PhD, Soffen, Edward, MD, Francke, Patrick, MD, Mantz, Constantine, MD, Rossi, Peter, MD, DeWeese, Theodore, MD, Daignault-Newton, Stephanie, MS, Fischer-Valuck, Benjamin W., MD, Chundury, Anupama, MD, Gay, Hiram, MD, Bosch, Walter, DSc, Michalski, Jeff, MD, MBA

“…Purpose SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial…”
Get full text

Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy by Mariados, Neil, MD, Sylvester, John, MD, Shah, Dhiren, MD, Karsh, Lawrence, MD, Hudes, Richard, MD, Beyer, David, MD, Kurtzman, Steven, MD, Bogart, Jeffrey, MD, Hsi, R. Alex, MD, Kos, Michael, MD, Ellis, Rodney, MD, Logsdon, Mark, MD, Zimberg, Shawn, MD, Forsythe, Kevin, MD, Zhang, Hong, MD, PhD, Soffen, Edward, MD, Francke, Patrick, MD, Mantz, Constantine, MD, Rossi, Peter, MD, DeWeese, Theodore, MD, Hamstra, Daniel A., MD, PhD, Bosch, Walter, DSc, Gay, Hiram, MD, Michalski, Jeff, MD, MBA

“…Purpose Perirectal spacing, whereby biomaterials are placed between the prostate and rectum, shows promise in reducing rectal dose during prostate cancer…”
Get full text

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors by Ramirez, Robert A., Beyer, David T., Chauhan, Aman, Boudreaux, J. Philip, Wang, Yi‐Zarn, Woltering, Eugene A.

“…Background. Neuroendocrine tumors (NETs) are commonly treated with multimodality therapy. The combination of capecitabine and temozolomide (CAPTEM) has been…”
Get full text

Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution by Woltering, Eugene A., MD, FACS, Voros, Brianne A., MS, Beyer, David T., BSBE, Wang, Yi-Zarn, DDS, MD, Thiagarajan, Ramcharan, MD, Ryan, Pamela, RN, BSN, Wright, Anne, RN, BSN, Ramirez, Robert A., DO, Ricks, M Jennifer, Boudreaux, J Philip, MD, FACS

“…Abstract Background Neuroendocrine tumors (NETs) are rare neoplasms. Our group has treated over 2,000 NET patients and has performed over 1,000 surgical…”
Get full text

Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation by Zelefsky, Michael J., M.D, Kuban, Deborah A., M.D, Levy, Larry B., Ph.D, Potters, Louis, M.D, Beyer, David C., M.D, Blasko, John C., M.D, Moran, Brian J., M.D, Ciezki, Jay P., M.D, Zietman, Anthony L., M.D, Pisansky, Thomas M., M.D, Elshaikh, Mohamed, M.D, Horwitz, Eric M., M.D

“…Purpose: To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved…”
Get full text

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer by Lukka, Himanshu R., Pugh, Stephanie L., Bruner, Deborah W., Bahary, Jean-Paul, Lawton, Colleen A.F., Efstathiou, Jason A., Kudchadker, Rajat J., Ponsky, Lee E., Seaward, Samantha A., Dayes, Ian S., Gopaul, Darindra D., Michalski, Jeff M., Delouya, Guila, Kaplan, Irving D., Horwitz, Eric M., Roach, Mack, Pinover, Wayne H., Beyer, David C., Amanie, John O., Sandler, Howard M., Kachnic, Lisa A.

“…There is considerable interest in very short (ultrahypofractionated) radiation therapy regimens to treat prostate cancer based on potential radiobiological…”
Get full text

A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526) by Crook, Juanita M., Zhang, Peixin, Pisansky, Thomas M., Trabulsi, Edouard J., Amin, Mahul B., Bice, William, Morton, Gerard, Pervez, Nadeem, Vigneault, Eric, Catton, Charles, Michalski, Jeff, Roach, Mack, Beyer, David, Jani, Ashesh, Horwitz, Eric, Donavanik, Viroon, Sandler, Howard

“…Only retrospective data are available for low-dose-rate (LDR) salvage prostate brachytherapy for local recurrence after external beam radiation therapy (EBRT)…”
Get full text

Anaerobically digested food waste in compost for Agaricus bisporus and Agaricus subrufescens and its effect on mushroom productivity by Stoknes, Ketil, Beyer, David M, Norgaard, Erik

“…Background Source‐separated food waste is increasingly being treated by means of hygienisation followed by anaerobic digestion. The fibrous digester residue…”
Get full text

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial by Michalski, Jeff M, Winter, Kathryn A, Prestidge, Bradley R, Sanda, Martin G, Amin, Mahul, Bice, William S, Gay, Hiram A, Ibbott, Geoffrey S, Crook, Juanita M, Catton, Charles N, Raben, Adam, Bosch, Walter, Beyer, David C, Frank, Steven J, Papagikos, Michael A, Rosenthal, Seth A, Barthold, H Joseph, Roach, 3rd, Mack, Moughan, Jennifer, Sandler, Howard M

“…To determine whether addition of external beam radiation therapy (EBRT) to brachytherapy (BT) (COMBO) compared with BT alone would improve 5-year freedom from…”
Get full text

Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy by Kupelian, Patrick, M.D, Willoughby, Twyla, M.Sc, Mahadevan, Arul, M.D, Djemil, Toufik, Ph.D, Weinstein, Geoffrey, M.D, Jani, Shirish, Ph.D, Enke, Charles, M.D, Solberg, Timothy, Ph.D, Flores, Nicholas, M.D, Liu, David, Ph.D, Beyer, David, M.D, Levine, Lisa, Ph.D

“…Purpose: To report the clinical experience with an electromagnetic treatment target positioning and continuous monitoring system in patients with localized…”
Get full text

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT) by Hartford, Alan C, Galvin, James M, Beyer, David C, Eichler, Thomas J, Ibbott, Geoffrey S, Kavanagh, Brian, Schultz, Christopher J, Rosenthal, Seth A

“…Intensity-modulated radiation therapy (IMRT) is a complex technique for the delivery of radiation therapy preferentially to target structures while minimizing…”
Get full text

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Transperineal Permanent Brachytherapy of Prostate Cancer by Rosenthal, Seth A., M.D, Bittner, Nathan H.J., M.D., M.S, Beyer, David C., M.D, Demanes, D. Jeffrey, M.D, Goldsmith, Brian J., M.D, Horwitz, Eric M., M.D, Ibbott, Geoffrey S., Ph.D, Lee, W. Robert, M.D, Nag, Subir, M.D, Suh, W. Warren, M.D, Potters, Louis, M.D

“…Transperineal permanent prostate brachytherapy is a safe and efficacious treatment option for patients with organ-confined prostate cancer. Careful adherence…”
Get full text

Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumors: Total Mesorectal Excision May Be Insufficient by Wang, Yi-Zarn, Beyer, David T., Hall, Michael

“…Background Optimal surgical treatment for small early rectal carcinoids is controversial. Large tumors (greater than 2 cm) and those with imaging evidence of…”
Get full text

Plasma Pancreastatin Predicts the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small Bowel by Woltering, Eugene A, Voros, Brianne A, Beyer, David T, Thiagarajan, Ramcharan, Ramirez, Robert A, Mamikunian, Gregg, Boudreaux, J Philip

“…Elevated pancreastatin (PST) levels have been shown to be associated with poor prognosis in small bowel neuroendocrine tumors (NETs). We hypothesized that…”
Get full text

Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum by Woltering, Eugene A., MD, FACS, Beyer, David T., BS, Thiagarajan, Ramcharan, MBBS, FACS, Ramirez, Robert A., DO, FACP, Wang, Yi-Zarn, MD, DDS, FACS, Ricks, M. Jennifer, Boudreaux, J. Philip, MD, FACS

“…Background Neuroendocrine tumors (NETs) of the duodenum are rare, heterogeneous, and often indolent neoplasms. We hypothesized that elevated pancreastatin…”
Get full text

Importance of Routine Bone Mineral Density Screening Prior to Elective Total Joint Replacement by Miller, Adam M., Beyer, David T., Starring, Hunter M., Leonardi, Claudia, Bronstone, Amy B., Dasa, Vinod

Get full text

Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer by Haffty, Bruce G, Beyer, David C, Kavanagh, Brian D

Get more information

Adjuvant radiation therapy, androgen deprivation, and docetaxel for high‐risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621 by Hurwitz, Mark D., Harris, Jonathan, Sartor, Oliver, Xiao, Ying, Shayegan, Bobby, Sperduto, Paul W., Badiozamani, Kasra R., Lawton, Colleen A. F., Horwitz, Eric M., Michalski, Jeff M., Roof, Kevin, Beyer, David C., Zhang, Qiang, Sandler, Howard M.

“…BACKGROUND Phase 3 trials have demonstrated a benefit from adjuvant radiation therapy (ART) for men who have adverse factors at radical prostatectomy (RP)…”
Get full text

American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT) by Hartford, Alan C., M.D., Ph.D, Palisca, Madeline G., M.S, Eichler, Thomas J., M.D, Beyer, David C., M.D, Devineni, Venkata Rao, M.D, Ibbott, Geoffrey S., Ph.D, Kavanagh, Brian, M.D., M.P.H, Kent, John S., M.S, Rosenthal, Seth A., M.D, Schultz, Chris J., M.D, Tripuraneni, Prabhakar, M.D, Gaspar, Laurie E., M.D., M.B.A

Get full text

Plasma Neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine Tumors of the Small Bowel by Woltering, Eugene A, Voros, Brianne A, Thiagarajan, Ramcharan, Beyer, David T, Ramirez, Robert A, Wang, Yi-Zarn, Mamikunian, Gregg, Boudreaux, J Philip

“…Elevated neurokinin A (NKA) levels are associated with poor prognosis in patients with small bowel neuroendocrine tumors. We hypothesized that patients with…”
Get full text